ITGB3 promotes cisplatin resistance in osteosarcoma tumors.
Li Q, Chen G, Jiang H, Dai H, Li D, Zhu K, Zhang K, Shen H, Xu H, Li S.
Li Q, et al. Among authors: li s, li d.
Cancer Med. 2023 Apr;12(7):8452-8463. doi: 10.1002/cam4.5585. Epub 2023 Feb 11.
Cancer Med. 2023.
PMID: 36772869
Free PMC article.